Maryland biotech significant in virus fight

WASHINGTON - As the world anxiously awaits a coronavirus vaccine, a Maryland biotechnology company already has signed deals to do initial production of three candidates. If one of them works, the firm has a factory in place to manufacture hundreds of millions of doses a year. Emergent BioSolutions of Gaithersburg has long been preparing for ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.